The health AI "super app" wants to add more nutrition data to its platform with this buy, its second acquisition of the yar.

directly through the telehealth platforms of Hims & Hers along with telehealth competitors LifeMD and Ro. Hims & Hers, LifeMD stocks skyrocket after inking deal with Novo Nordisk to sell Wegovy ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a fortune off the popularity of weight loss injections.

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Monday, Leerink Partners maintained a Market Perform rating and a $40.00 price target on Hims & Hers Health, Inc. (NYSE: HIMS) shares.The firm’s analyst highlighted the appointment of Nader ...

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...

To get there, Hims will need to be more than just another distributor of Wegovy. Rival telehealth platforms Ro and LifeMD have also made deals with Novo to sell the drug. Customers who have grown ...

As part of its deal with Novo, Hims, along with LifeMD Inc., and Ro will sell a month’s supply of Wegovy starting at $499, a 63% discount, before subscription fees. Lilly also announced an ...